Dementia starts with biological changes in the brain that can begin 20 years or more before any noticeable symptoms appear. During this silent phase, abnormal proteins slowly accumulate and damage brain cells, eventually causing the memory lapses, confusion, and personality shifts that most people associate with the disease. Understanding what happens during those hidden years, and recognizing the subtle early signs, can make a real difference in how early the condition is caught.
What Happens in the Brain First
In the most common form of dementia, Alzheimer’s disease, the process begins with a protein called beta-amyloid. Fragments of this protein clump together into sticky plaques that collect between brain cells. This accumulation happens gradually, and a person may show no signs of cognitive trouble for two decades after the first plaques form. A second protein, tau, then begins twisting into tangles inside the brain cells themselves, disrupting communication between neurons and eventually killing them.
The damage follows a predictable path. It typically starts in a small area deep in the brain involved in forming new memories, then spreads to the hippocampus (the brain’s main memory hub), then outward to the regions responsible for language, reasoning, and behavior. By the time someone notices they’re forgetting things more than usual, significant cell loss has already occurred in these early-hit regions.
By age 70, roughly one-third of people with no cognitive symptoms already have elevated levels of amyloid in their brains. Not all of them will develop dementia, but the buildup does increase their risk. How quickly someone moves from silent protein accumulation to noticeable problems depends on several factors, including age, sex, and genetics. Being older when amyloid starts accumulating tends to shorten the window between buildup and symptoms. Being female also appears to compress that timeline.
Genetics and the APOE Connection
The gene most strongly linked to common, late-onset Alzheimer’s is APOE, specifically the ε4 variant. Everyone inherits two copies of the APOE gene, and carrying even one copy of the ε4 version raises your risk and is associated with amyloid accumulating at a younger age. Carrying two copies raises the risk further. That said, some people with two copies never develop dementia, and many people who develop Alzheimer’s carry no ε4 copies at all. The degree of risk also varies by genetic ancestry, differing among people of African, Asian, American Indian, and European descent.
Rare genetic mutations cause a small fraction of Alzheimer’s cases, typically striking people in their 40s or 50s. But for the vast majority of people, dementia results from a combination of genetic susceptibility, aging, and lifestyle factors rather than a single inherited gene.
The Earliest Warning Signs
Most people expect memory loss to be the first red flag, and for Alzheimer’s it often is. But the earliest changes are frequently so mild they get dismissed as normal aging or stress. You might notice difficulty remembering recent conversations, misplacing items more often, struggling to find the right word, or taking longer to complete familiar tasks like managing finances or following a recipe.
What many people don’t realize is that non-cognitive symptoms often appear early too, sometimes before obvious memory problems. Research tracking people who later developed Alzheimer’s found that irritability, depression, and changes in nighttime behavior (like restless sleep or waking frequently) tend to emerge first. As the disease progresses, these are followed by anxiety, appetite changes, agitation, and apathy. A noticeable drop in energy and interest in activities, along with a growing preference for staying home, are also common early patterns. These shifts can be easy to attribute to aging, retirement, or life circumstances rather than a brain disease.
How Vascular Dementia Starts Differently
Not all dementia begins the same way. Vascular dementia, the second most common type, is caused by reduced blood flow to the brain, often from small strokes or damaged blood vessels. Its early symptoms look quite different from Alzheimer’s. Memory loss is not usually the main early sign. Instead, the first problems tend to involve planning, organizing, making decisions, or following a series of steps. Thinking speed slows down noticeably, and there may be short periods of sudden confusion.
The onset pattern differs too. Alzheimer’s typically develops as a slow, steady decline. Vascular dementia can progress in a stepwise fashion, with sudden drops in ability (often after a small stroke) followed by periods of stability. Some people experience both types simultaneously, a condition called mixed dementia, which can make early symptoms harder to pin down.
Mild Cognitive Impairment: The In-Between Stage
Between normal aging and dementia sits a stage called mild cognitive impairment, or MCI. People with MCI have measurable declines in memory or thinking that go beyond what’s expected for their age, but they can still handle daily life independently. You might need to write more things down, or a family member might notice you repeating questions, but you can still drive, cook, manage medications, and live on your own.
MCI doesn’t always lead to dementia. In the general population, roughly 4 to 5 percent of people with MCI progress to dementia each year. Some remain stable for years, and a small percentage actually improve. But MCI is the stage where early detection matters most, because it represents the clearest window for intervention. On neuropsychological tests, MCI is typically identified when scores fall one to two standard deviations below what’s expected for someone of the same age and education level.
How Early Detection Is Changing
Historically, confirming Alzheimer’s required either a brain scan to detect amyloid or, ultimately, an autopsy. That’s changing. Blood tests measuring a specific form of the tau protein (p-tau217) can now detect Alzheimer’s-related brain changes with high accuracy, even at the preclinical stage before symptoms appear. In recent studies, this blood test achieved sensitivity rates between 85 and 98 percent, meaning it correctly identified the disease in the vast majority of people who had it. Specificity ranged from about 75 to 85 percent, meaning it also correctly ruled out most people who didn’t have it.
These tests are not yet routine in most clinical settings, but they represent a significant shift toward catching the disease years earlier than was previously possible. Earlier detection opens the door to treatments that target amyloid buildup, which are most effective when brain damage is still limited.
Risk Factors You Can Actually Change
Perhaps the most empowering finding in dementia research is that a large share of cases are not inevitable. The 2024 Lancet Commission identified 14 modifiable risk factors that collectively account for roughly 45 percent of dementia cases worldwide. These include hearing loss (one of the largest single contributors), high blood pressure in midlife, less education, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol use, traumatic brain injury, air pollution, social isolation, and poor sleep.
None of these guarantees dementia, and addressing them doesn’t guarantee prevention. But the numbers are striking: nearly half of all cases worldwide are linked to factors that are, at least in principle, within reach of change. Treating hearing loss with hearing aids, staying physically active, managing blood pressure starting in your 40s, maintaining social connections, and protecting sleep quality are among the most impactful steps supported by current evidence. The earlier in life these factors are addressed, the greater the protective effect appears to be.